Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TXNRD1 | Q16881 | 5/20 | 0.39 |
| ▸ | FBP1 | P09467 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7968000 | 0.82 | FBP1 (0.36) | TXNRD1FBP1KMT2AALDH1A1MEN1 | |
| SCHEMBL47790 | 0.81 | TSHR (0.42) | FBP1KMT2AALDH1A1MEN1KDM4E | |
| SCHEMBL47791 | 0.81 | TSHR (0.42) | FBP1KMT2AALDH1A1MEN1KDM4E | |
| SCHEMBL8699266 | 0.75 | FBP1 (0.37) | FBP1KMT2AALDH1A1MEN1KDM4E | |
| Hydrochloric Acid SCHEMBL28016724 | 0.74 | GAA (0.38) | FBP1KMT2AALDH1A1MEN1KDM4E | |
| SCHEMBL27364415 | 0.73 | CTSV (0.46) | KMT2AMEN1TDP1L3MBTL1POLB | |
| SCHEMBL27311411 | 0.71 | ALDH1A1 (0.41) | FBP1KMT2AALDH1A1MEN1KDM4E | |
| SCHEMBL10527838 | 0.70 | TXNRD1 (0.43) | TXNRD1KMT2AALDH1A1MEN1KDM4E | |
| SCHEMBL27837566 | 0.69 | SIRT6 (0.44) | KMT2AALDH1A1MEN1KDM4ELMNA | |
| SCHEMBL28102381 | 0.69 | ALDH1A1 (0.46) | KMT2AALDH1A1MEN1TDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2013115813-A1 | WATER SOLUBLE SOLID PHASE PEPTIDE SYNTHESIS | CEM CORPORATION (US) | 2013-08-08 | — | — | WO | disclosed |
| US-20120157563-A1 | WATER SOLUBLE SOLID PHASE PEPTIDE SYNTHESIS | CEM CORPORATION (US) | 2012-06-21 | — | — | US | disclosed |
| US-20120041173-A1 | WATER SOLUBLE SOLID PHASE PEPTIDE SYNTHESIS | CEM CORPORATION (US) | 2012-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157563-A1 | WATER SOLUBLE SOLID PHASE PEPTIDE SYNTHESIS | SPAST, DNPEP, SSU72 | TXNRD1 1868/4885FBP1 2499/4885KMT2A 4018/4885 |
| US-20120041173-A1 | WATER SOLUBLE SOLID PHASE PEPTIDE SYNTHESIS | ADH1C, SSU72, ADH1A | TXNRD1 1262/4885FBP1 2471/4885KMT2A 4059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.